Login

Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q2 FY2023
As of Jun 30, 2023
Q3 FY2023
As of Sep 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
ASSETS
Cash
Deferred offering costs
Prepaid expenses
Cash and marketable securities held in trust account
Total Current Assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities
Accrued expenses
Promissory note – related party
Franchise tax payable
Income tax payable
Excise tax payable
Working capital loan – related party
Related Party
Total working capital loan – related party
Extension loans – related party
Deferred underwriter fee payable
Amount due to redeemed public shareholders
Total Current Liabilities
Deferred underwriter fee payable
Total Liabilities
Class A common stock subject to possible redemption; 1,702,285 and 2,991,003 shares (at redemption value of $10.95 and $10.59 per share as of September 30, 2024 and December 31, 2023, respectively)
Common Class A
Total class A common stock subject to possible redemption; 1,702,285 and 2,991,003 shares (at redemption value of $10.95 and $10.59 per share as of September 30, 2024 and December 31, 2023, respectively)
Stockholders’ Deficit
Common stock, value
Common Class A
Common Class B
Additional paid-in capital
Accumulated deficit
Total Stockholders’ Deficit
Total Liabilities and Stockholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support